Literature DB >> 2041093

In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies.

F Komurian1, F Pelloquin, G de Thé.   

Abstract

To investigate the geography- and disease-associated genomic variation of human T-cell leukemia virus type I (HTLV-I), we studied ex vivo DNA from peripheral blood lymphocytes from nine patients by polymerase chain reaction and direct DNA sequencing. For each viral strain, 1,917 bp was sequenced, including parts of the long terminal repeat, the env gene, and the px II, px III, and px IV coding frames of the px region. The number of genomic variations observed in the U3 region of the long terminal repeat was higher than that seen in the env and px genes. Very few mutations were present in the px II and px III genes. In contrast, the px IV open reading frame exhibited numerous single point mutations. While no specific mutation could be linked to any pathology (adult T-cell leukemia/lymphoma or tropical spastic paraparesis/HTLV-I-associated myelopathy), variations among HTLV-I isolates from different geographic areas (Ivory Coast, Caribbean, and Japan) existed. The Ivory Coast HTLV-I appeared to represent a group by itself.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041093      PMCID: PMC241407     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes.

Authors:  A J Cann; J D Rosenblatt; W Wachsman; I S Chen
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

2.  Activation of the human T-cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate and by tax (p40x) occurs through similar but functionally distinct target sequences.

Authors:  M Radonovich; K T Jeang
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins.

Authors:  E Böhnlein; M Siekevitz; D W Ballard; J W Lowenthal; L Rimsky; H Bogérd; J Hoffman; Y Wano; B R Franza; W C Greene
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product.

Authors:  S Ruben; H Poteat; T H Tan; K Kawakami; R Roeder; W Haseltine; C A Rosen
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

5.  Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients.

Authors:  E P Reddy; M Sandberg-Wollheim; R V Mettus; P E Ray; E DeFreitas; H Koprowski
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

6.  Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP.

Authors:  H T Poteat; P Kadison; K McGuire; L Park; R E Park; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence.

Authors:  K T Jeang; I Boros; J Brady; M Radonovich; G Khoury
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM).

Authors:  A Tsujimoto; T Teruuchi; J Imamura; K Shimotohno; I Miyoshi; M Miwa
Journal:  Mol Biol Med       Date:  1988-02

9.  Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.

Authors:  J E LoSardo; L A Cupelli; M K Short; J W Berman; J Lenz
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Enzymatic amplification of exogenous and endogenous retroviral sequences from DNA of patients with tropical spastic paraparesis.

Authors:  C R Bangham; S Daenke; R E Phillips; J K Cruickshank; J I Bell
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  38 in total

1.  Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

Authors:  W Heneine; R F Khabbaz; R B Lal; J E Kaplan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.

Authors:  Yoshimi Enose-Akahata; Anna Abrams; Kory R Johnson; Elizabeth M Maloney; Steven Jacobson
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

3.  HTLV-I associated sicca syndrome in Guadeloupe: lack of relation with a peculiar encoding sequence of surface envelope glycoprotein.

Authors:  A Georges-Gobinet; D Moynet; C Hajjar; S Sainte-Foie; J Savin; B Guillemain
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins.

Authors:  F J Picard; M B Coulthart; J Oger; E E King; S Kim; J Arp; G P Rice; G A Dekaban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1.

Authors:  F Ibrahim; G de Thé; A Gessain
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.

Authors:  A Gessain; R C Gallo; G Franchini
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background.

Authors:  T Miura; T Fukunaga; T Igarashi; M Yamashita; E Ido; S Funahashi; T Ishida; K Washio; S Ueda; K Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.

Authors:  V Maguer; H Cassé-Ripoll; L Gazzolo; M D Dodon
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.

Authors:  S Niewiesk; C R Bangham
Journal:  J Mol Evol       Date:  1996-04       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.